【摘要】 目的 :对治疗肺结核的两种化疗方案进行比较并阐明力克肺疾的作用机制 ;方法 :采用中国防痨协会制定的菌阳肺结核病诊断标准及疗效判定我们对 8年来 10 0例菌阳肺结核病人应用含力克肺疾与不含力克肺疾两种化疗方案进行比较 ;结果 :对 10 0例菌阳肺结核病例进行统计学分析 ,菌阳初治病例实验组与对照组 3个月及 6个月痰菌阴转率 ,胸片病灶好转率无显著差异 (P >0 0 5 ) ;菌阳复治病例 4个月及 8个月痰菌阴转率及症状改善率有显著差异(P <0 0 5 ) ;二种菌阳病例治疗过程中毒副反应发生率相比有显著差异 (P <0 0 5 ) ;结论 :力克肺疾是一种安全、有效的抗结核药物。更多还原

【Abstract】 Objective:To compare the effect of two chemontherapy and illustrate the effective mechanism of dipasic;Methods:The standard diagnosis and treatment outcome of smear positive pulmonary tuberculosis designed by chinese Antituberculosis Association;Comparing the experimental group and control group to treat 100 case with smear positive pulmonary tuberculosis admitted in our hospital in the last 8 years;Result:The comparison of treatment outcome of the 100 cases showed that,newly diagnosed smear positive case after 3 and 6 months treatment the improving rate of chest x-ray and sputum conversion were same in two groups.Oldly diagosed smear positive cases of per 4 and 8 months,sputum conversion and improvment of symptom is significantly different between the two growps(P<0.05).Conclusion:Dipasic is a safty and effective drug in curing tuberculosis.更多还原